A Systematic Review Found Cannabinoids Can Cause Brain Damage Leading to Psychiatric, Cognitive, and Neurological Disorders

Across 30 human studies, cannabinoid consumption was associated with psychiatric, neurocognitive, and neurological disorders, with high-potency synthetic cannabinoids posing the greatest risks, including rare cases of death from acute consumption.

Scopetti, Matteo et al.·Current pharmaceutical biotechnology·2023·Moderate EvidenceSystematic Review
RTHC-04922Systematic ReviewModerate Evidence2023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Systematic Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Cannabinoid consumption is associated with psychiatric disorders, neurocognitive impairment, neurological disorders, and in some cases of acute consumption of synthetic cannabinoids, death. Synthetic cannabinoids carry the greatest risks, but phytocannabinoid use is not devoid of neurotoxic potential.

Key Numbers

30 papers included. Risks highest with high-potency synthetic cannabinoids. Phytocannabinoids also carry risks. Acute synthetic cannabinoid use linked to death in some cases.

How They Did This

Systematic literature search through PubMed and Scopus using specific search terms for cannabinoid brain damage/toxicity. Critical appraisal of collected studies. 30 papers included examining toxic brain effects in human subjects.

Why This Research Matters

As cannabis becomes more socially accepted, the neurotoxicity risks are increasingly overlooked. This review serves as a corrective, documenting that brain damage from cannabinoids is a real clinical phenomenon, not just a theoretical concern.

The Bigger Picture

The review calls for reinforcing toxicological monitoring of new synthetic substances and better public education. The message is not that all cannabis use causes brain damage, but that the risks are real and underappreciated, especially with synthetic products.

What This Study Doesn't Tell Us

Systematic review but limited to 30 studies. Heterogeneous study designs and cannabinoid types. Cannot establish dose-response relationships from included studies. May overrepresent severe cases. Search terms may have missed relevant studies.

Questions This Raises

  • ?What dose thresholds distinguish safe from neurotoxic cannabinoid exposure?
  • ?Should synthetic cannabinoid monitoring be integrated with standard toxicology surveillance?

Trust & Context

Key Stat:
Synthetic cannabinoid use was linked to brain damage and death in some cases
Evidence Grade:
Systematic review of 30 human studies with critical appraisal. Limited by study heterogeneity.
Study Age:
Published in 2023.
Original Title:
Cannabinoids and Brain Damage: A Systematic Review on a Frequently Overlooked Issue.
Published In:
Current pharmaceutical biotechnology, 24(6), 741-757 (2023)
Database ID:
RTHC-04922

Evidence Hierarchy

Meta-Analysis / Systematic ReviewCombines many studies into one answer
This study
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Analyzes all available research on a topic using a structured method.

What do these levels mean? →

Frequently Asked Questions

Can cannabis damage the brain?

This systematic review of 30 human studies found cannabinoid use is associated with psychiatric, cognitive, and neurological disorders. Synthetic cannabinoids carry the greatest risk, but natural cannabis use is not risk-free.

Are synthetic cannabinoids more dangerous?

Yes. High-potency synthetic cannabinoids were associated with the most severe outcomes, including neurological damage and death in some acute cases.

Read More on RethinkTHC

Cite This Study

RTHC-04922·https://rethinkthc.com/research/RTHC-04922

APA

Scopetti, Matteo; Morena, Donato; Manetti, Federico; Santurro, Alessandro; Fazio, Nicola Di; D'Errico, Stefano; Padovano, Martina; Frati, Paola; Fineschi, Vittorio. (2023). Cannabinoids and Brain Damage: A Systematic Review on a Frequently Overlooked Issue.. Current pharmaceutical biotechnology, 24(6), 741-757. https://doi.org/10.2174/1389201023666220614145535

MLA

Scopetti, Matteo, et al. "Cannabinoids and Brain Damage: A Systematic Review on a Frequently Overlooked Issue.." Current pharmaceutical biotechnology, 2023. https://doi.org/10.2174/1389201023666220614145535

RethinkTHC

RethinkTHC Research Database. "Cannabinoids and Brain Damage: A Systematic Review on a Freq..." RTHC-04922. Retrieved from https://rethinkthc.com/research/scopetti-2023-cannabinoids-and-brain-damage

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.